These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2416888)

  • 1. Reversible increase in serum alpha-fetoprotein content associated with hepatic dysfunction during chemotherapy for seminoma.
    Grem JL; Trump DL
    J Clin Oncol; 1986 Jan; 4(1):41-5. PubMed ID: 2416888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of advanced testicular seminoma--chemotherapy and serum marker].
    Nakamura K; Hagiwara M; Aikawa A; Deguchi N; Tazaki H; Takeshita E; Ito S
    Gan No Rinsho; 1983 Dec; 29(15):1779-82. PubMed ID: 6199531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of disseminated seminoma.
    Einhorn LH; Williams SD
    Cancer Clin Trials; 1980; 3(4):307-13. PubMed ID: 6159120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of bilateral germ cell tumor of the testis].
    Saito M; Kondo A; Kinjo T
    Hinyokika Kiyo; 1989 Nov; 35(11):1961-4. PubMed ID: 2482675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy of extragonadal germ cell tumors.
    Logothetis CJ; Samuels ML; Selig DE; Dexeus FH; Johnson DE; Swanson DA; von Eschenbach AC
    J Clin Oncol; 1985 Mar; 3(3):316-25. PubMed ID: 2579212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced dose PVB treatment of stage IIC-IV testicular seminoma.
    Berkmen F
    Eur J Surg Oncol; 1993 Feb; 19(1):24-6. PubMed ID: 7679655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors.
    Vogelzang NJ; Lange PH; Goldman A; Vessela RH; Fraley EE; Kennedy BJ
    Cancer Res; 1982 Nov; 42(11):4855-61. PubMed ID: 6181870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An autopsy case revealing bilateral successive testicular germ cell tumors of different cell types].
    Tsukamoto H; Atari E; Okudaira M; Uchida T; Kobayashi K; Ishibashi A; Koshiba K
    Gan No Rinsho; 1988 Apr; 34(4):505-10. PubMed ID: 2451763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer.
    de Wit R; Sylvester R; Tsitsa C; de Mulder PH; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; van Oosterom AT; Boven E; Vermeylen K; Stoter G
    Br J Cancer; 1997; 75(3):432-5. PubMed ID: 9020492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy.
    Pinkerton CR; Pritchard J; Spitz L
    J Clin Oncol; 1986 Feb; 4(2):194-9. PubMed ID: 2418168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The place of surgery in the treatment of seminomatous testicular tumors.
    Smith RB
    Prog Clin Biol Res; 1984; 153():111-9. PubMed ID: 6206504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stage II non-seminoma cancer of the testis: combined treatment with surgery and chemotherapy].
    Orlandi L; Van Cauwelaert R; Orlandi F; Vargas R; San Martín S; Arraztoa J
    Actas Urol Esp; 1989; 13(1):53-5. PubMed ID: 2469300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of a locally advanced testicular seminoma without metastases. A case report.
    Abratt RP; Pontin AR; Sarembock LA
    S Afr Med J; 1987 Aug; 72(3):212. PubMed ID: 2440118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up.
    Levi JA; Thomson D; Sandeman T; Tattersall M; Raghavan D; Byrne M; Gill G; Harvey V; Burns I; Snyder R
    J Clin Oncol; 1988 Jul; 6(7):1154-60. PubMed ID: 2455778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VAB-6 chemotherapy causes spurious elevation of alpha-fetoprotein associated with liver dysfunctions.
    Hida S; Nishimura K; Nishio Y; Oishi K; Takeuchi H; Yoshida O
    Urol Int; 1991; 46(1):1-5. PubMed ID: 1708922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary intracranial malignant germ cell tumor associated with abnormal high value of alpha-fetoprotein and human chorionic gonadotropin].
    Nishiyama K; Nishida K; Kusaka K; Morizumi H
    No Shinkei Geka; 1987 Dec; 15(12):1337-42. PubMed ID: 2452372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [False-positive elevation of alpha-fetoprotein during induction chemotherapy in patients with testicular cancer].
    Hida S; Kawakita M; Oishi K; Okada Y; Takeuchi H; Okada K; Yoshida O
    Hinyokika Kiyo; 1986 Dec; 32(12):1859-66. PubMed ID: 2435135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [VAB-6 combination chemotherapy in patients with stage II, III testicular tumor].
    Hida S; Kawakita M; Takenawa J; Fukuzawa S; Okuno H; Yamauchi T; Oishi K; Nishio Y; Takeuchi H; Okada K
    Hinyokika Kiyo; 1986 Dec; 32(12):1849-58. PubMed ID: 2435134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Germ cell testicular tumors: understanding the kinetics of serum alpha-fetoprotein (AFP) during chemotherapy].
    Riedinger JM; Eche N; Chevreau C; Fargeot P
    Ann Biol Clin (Paris); 2008; 66(5):523-30. PubMed ID: 18957341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors].
    Mori Y; Shima H; Ihara H; Yabumoto H; Iwasaki A; Yoshioka M; Ikoma F
    Hinyokika Kiyo; 1992 Oct; 38(10):1139-42. PubMed ID: 1282774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.